ÂÜÀòÂÒÂ×

Michael Wynne is a seasoned professional in clinical genetic and oncology sales with extensive experience in the medical device and diagnostics industry. Currently serving as the Clinical Genetic / Oncology Sales Manager at Otogenetics Corporation since November 2024, Michael previously held the position of Senior Clinical Oncology Specialist at Fulgent Genetics. Prior roles include Clinical Market Development Manager and Clinical Biomarker Specialist at Biocept, where focus was on liquid biopsy testing services, and Strategic Account Manager at ImpediMed, with expertise in fluid measurement and body composition solutions. Michael's background also includes positions as Territory Manager for Surgical and Neuro Oncology at AngioDynamics and Novocure, and previous roles at Terumo Medical Corporation, Boston Scientific, Zimmer Dental, and Canon Solutions America. Michael holds a Bachelor of Science degree in Psychology from the University of Illinois Urbana-Champaign.